Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRSA decolonization trial: doxycycline + rifampicin versus trimethoprim + rifampicin
NL-OMON51735Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in methicillin-resistant Staphylococcus aureus carriage comparing Doxycycline + rifampicin with Trimethoprim + rifampicin (2 arms). Primary endpoint: Successful MRSA decolonization. Started May 2022; status: recruiting.
02
Drugs
doxycyclinerifampicintrimethoprim
03
Conditions
methicillin-resistant Staphylococcus aureus carriage
Beyond the preview
Go deeper on NL-OMON51735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51735.